FDA put a clinical hold on further development of an intravitreal gene therapy, it was a serious setback for the Sponsor, as well as hopeful patients. Experts discuss challenges and solutions for success in gene therapy clinical development

https://discover.emmes.com/ophthalmic-gene-therapy-study
FDA put a clinical hold on further development of an intravitreal gene therapy, it was a serious setback for the Sponsor, as well as hopeful patients. Experts discuss challenges and solutions for success in gene therapy clinical development
Case Study